A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Clinical trial NCT04635800 · COMPLETED

Trial details

NCT number: NCT04635800
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Macular Edema Diabetic Macular Edema Neovascular Age-related Macular Degeneration Retinal Vein Occlusion

Start date: 2020-12-10
Primary completion: 2022-05-24
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.